Watchlist Price Alert

Sio Gene Therapies Inc. (SIOX)

NASDAQ: SIOX · Real-Time Price · USD

0.48

0.09 (23.14%)

At close: Feb 07, 2024, 8:58 PM

Sio Gene Therapies Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-4.62M	-3.14M	-8.53M	-13.28M	-25.45M	-21.2M	-11.92M	-12.21M	-10.61M	-9.55M	-9.83M	-16.05M	-13.68M	-11.88M	-27.56M	-13.31M	-32.42M	-32.12M	-49.17M	-24.04M	-55.38M	-68.67M	-65.23M	-53.1M	-47.97M	-41.52M	-37.91M	-30.59M	-62.55M	-12.04M	-27.98M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-4.02M	-3.08M	-8.41M	-13.04M	-25.46M	-21.24M	-11.9M	-3.24M	-10.7M	-10.13M	-8.56M	-16.37M	-14.05M	-13.76M	-28.02M	-9.14M	-34.24M	-33.74M	-51.81M	-25.35M	-57.88M	-70.68M	-66.75M	-54.61M	-47.97M	-41.52M	-37.91M	-30.59M	-62.55M	-12.04M	-27.98M
Net Income	-3.42M	-3.02M	-8.41M	-13.32M	-25.46M	-21.24M	-11.87M	-3.33M	-10.52M	-9.98M	-8.59M	-16.65M	-14.04M	-13.88M	-28.06M	-9.05M	-34.3M	-33.84M	-51.89M	-25.32M	-57.9M	-69.09M	-69.27M	-52.83M	-47.81M	-42.25M	-38.05M	-29.67M	-63.36M	-12.06M	-28.06M
Selling & General & Admin	2.6M	2.94M	2.99M	470K	4.09M	9.75M	3.86M	3.96M	4.2M	4.49M	4.64M	5.13M	5.41M	5.05M	6.47M	6.16M	10.93M	10.62M	11.75M	2.24M	18.03M	30.11M	21.52M	12.3M	11.34M	9.45M	12.63M	7.15M	28.23M	3.76M	17.38M
Research & Development	1.88M	336K	5.54M	12.61M	21.29M	11.45M	8.06M	8.24M	6.41M	5.06M	5.19M	10.92M	8.27M	6.83M	21.09M	7.15M	21.48M	21.5M	37.42M	21.8M	37.35M	38.55M	43.71M	40.8M	36.63M	32.07M	25.28M	23.43M	34.32M	8.28M	10.61M
Other Expenses	464K	197K	124K	47K	-76K	-30K	20K	8.97M	-98K	-580K	2.07M	127K	694K	-560K	1.1M	5.89M	78K	315K	-668K	535K	-550K	-131K	357K	-369K	47.97M	41.52M	37.91M	n/a	62.55M	n/a	n/a
Operating Expenses	4.48M	3.28M	8.53M	13.08M	25.37M	21.2M	11.92M	12.21M	10.61M	9.55M	9.83M	16.05M	13.68M	11.88M	27.56M	13.31M	32.42M	32.12M	49.17M	24.04M	55.38M	68.67M	65.23M	53.1M	47.97M	41.52M	37.91M	30.59M	62.55M	12.04M	27.98M
Interest Expense	n/a	n/a	n/a	8K	7K	11K	1K	1K	1K	1K	796K	440K	1.07M	1.31M	1.56M	1.72M	1.91M	1.93M	1.97M	1.84M	1.95M	1.88M	1.87M	1.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.48M	3.28M	8.53M	13.08M	25.37M	21.2M	11.92M	12.21M	10.61M	9.55M	9.83M	16.05M	13.68M	11.88M	27.56M	13.31M	32.42M	32.12M	49.17M	24.04M	55.38M	68.67M	65.23M	53.1M	47.97M	41.52M	37.91M	30.59M	62.55M	12.04M	27.98M
Income Tax Expense	-601K	-63K	-4K	287K	-69K	-19K	-28K	92K	-188K	-146K	30K	282K	-9K	127K	38K	-91K	52K	94K	78K	-32K	24K	-1.59M	2.52M	-1.78M	-161K	729K	148K	-918K	802K	24K	74K
Shares Outstanding (Basic)	73.98M	73.98M	73.77M	73.71M	73.34M	72.94M	72.86M	65.98M	52.68M	46.73M	43.29M	25M	22.79M	22.78M	22.78M	19.96M	16.1M	15.11M	13.47M	13.46M	13.46M	13.45M	13.3M	12.4M	12.4M	12.4M	12.39M	12.39M	12.39M	12.39M	10.04M
Shares Outstanding (Diluted)	73.98M	73.98M	73.77M	73.71M	73.34M	72.94M	72.86M	66.25M	52.68M	46.73M	43.29M	25M	22.79M	22.78M	22.78M	19.96M	16.1M	15.11M	13.47M	13.46M	13.46M	13.45M	13.3M	12.4M	12.4M	12.4M	12.39M	12.39M	12.39M	12.39M	10.04M
EPS (Basic)	-0.05	-0.04	-0.11	-0.18	-0.35	-0.29	-0.16	-0.05	-0.2	-0.21	-0.2	-0.67	-0.62	-0.61	-1.23	-0.45	-2.13	-2.24	-3.85	-1.88	-4.3	-5.14	-5.21	-4.26	-3.86	-3.41	-3.07	-2.39	-5.11	-0.97	-2.8
EPS (Diluted)	-0.05	-0.04	-0.11	-0.18	-0.35	-0.29	-0.16	-0.05	-0.2	-0.21	-0.2	-0.67	-0.62	-0.61	-1.23	-0.45	-2.13	-2.24	-3.85	-1.88	-4.3	-5.14	-5.21	-4.26	-3.86	-3.41	-3.07	-2.39	-5.11	-0.97	-2.8
EBITDA	n/a	n/a	n/a	-13.03M	-25.25M	-21.11M	-11.79M	-3.24M	-10.7M	-9.51M	-6.85M	-15.21M	-12.13M	n/a	-25.67M	-7.42M	-32.34M	-31.2M	n/a	-22.54M	n/a	n/a	-64.54M	-53.47M	n/a	n/a	n/a	-30.58M	n/a	n/a	n/a
EBIT	n/a	n/a	n/a	-13.03M	-25.52M	-21.21M	-11.9M	5.45M	-10.7M	-10.13M	-7.77M	-15.36M	-12.98M	-11.13M	-26.46M	-129K	-32.34M	-31.81M	-47.87M	-21.13M	-53.98M	-66.92M	-64.87M	-52.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	137K	-134K	271K	250K	194K	112K	110K	289K	636K	622K	919K	716K	849K	734K	795K	327K	476K	613K	1.03M	970K	1.06M	715K	335K	214K	13K	11K	11K	6K	-6K	13K	1K